Sign In
Buy EVLO
$0.0001
+0 (+0%)
At Close: Jun 22, 2026
Evelo Biosciences Reports Fourth Quarter and Full Year 2019 Financial Results and Business Highlights
12:00pm, Thursday, 13'th Feb 2020
—Strong 2019 marked by clinical data that validates platform——Lead inflammation candidate EDP1815 showed positive clinical data across two separate cohorts——EDP1815 Phase 2.
The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight
08:22pm, Sunday, 09'th Feb 2020
Biotech stocks recovered last week along with the broader markets, which bounced back from a China coronavirus-induced sell-off. Big pharma earnings took the spotlight, with Merck & Co., Inc. (NYSE: M
Evelo Biosciences to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, February 13, 2020
01:00pm, Thursday, 06'th Feb 2020
Evelo Biosciences (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that it will host a conference call and l
Flagship Pioneering Announces Ohana Biosciences
11:05am, Monday, 27'th Jan 2020
Flagship Pioneering, a unique life sciences innovation enterprise, today announced a first-in-category reproductive health company, Ohana Biosciences. Ohana is embarking on a fresh approach to the fie
Evelo Biosciences, Inc. (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today provided an update on recent positive regulat
Hedge Funds Have Never Been This Bullish On Evelo Biosciences, Inc. (EVLO)
11:39pm, Friday, 20'th Dec 2019
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the t
Flagship Unveils Newest Pioneering Platform: Ring Therapeutics
01:00pm, Thursday, 19'th Dec 2019
Flagship Pioneering, a unique life sciences innovation enterprise, today announced the launch of Ring Therapeutics, an early-stage biotechnology company developing first-in-class gene therapies using
Evelo Biosciences Appoints Juan Andres to Board of Directors
12:00pm, Thursday, 05'th Dec 2019
Evelo Biosciences, Inc. (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced the appointment of biopharmaceutica
Evelo Biosciences to Present at the Stifel 2019 Healthcare Conference
01:01pm, Wednesday, 13'th Nov 2019
Evelo Biosciences, Inc. (EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that management will present a corp
